Patent application number | Description | Published |
20080261978 | Chemokine receptor modulators - The invention provides compounds of Formula (I) | 10-23-2008 |
20080293711 | Chemokine receptor modulators - The invention provides compounds of Formula (I) | 11-27-2008 |
20100029634 | Chemokine Receptor Modulators - The invention provides compounds of Formula (I) | 02-04-2010 |
20110263553 | STEROID ANALOGUES FOR NEUROPROTECTION - Provided are steroid analogues functionalized with polar substituents at the C3 and/or C20 positions of the steroid ring system that exhibit improved water solubility. Also provided are pharmaceutical compositions comprising the steroid analogues and methods using the novel steroid analogues for the treatment and prevention of neurodegeneration in a patient following injury to the central nervous system. | 10-27-2011 |
20130172330 | Chemokine Receptor Modulators - The invention provides compounds of Formula (I) | 07-04-2013 |
20130210785 | PROGESTERONE ANALOGS AND USES RELATED THERETO - This disclosure relates to progesterone derivatives and uses related thereto. In certain embodiments, the disclosure relates to compounds disclosed herein and uses for managing inflammation resulting from traumatic brain injury or stroke. | 08-15-2013 |
20130324552 | CHEMOKINE CXCR4 RECEPTOR MODULATORS AND USED RELATED THERETO - The disclosure relates to chemokine CXCR4 receptor modulators and uses related thereto. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising compounds disclosed herein or pharmaceutically acceptable salts or prodrugs thereof. In certain embodiments, the compositions disclosed herein are used for managing CXCR4 related conditions, typically prevention or treatment of viral infections such as HIV or for managing cancer. | 12-05-2013 |
20140248236 | TRICYCLIC AMINO CONTAINING COMPOUNDS FOR TREATMENT OR PREVENTION OF SYMPTOMS ASSOCIATED WITH ENDOCRINE DYSFUNCTION - The disclosure provides methods of use of certain compounds that are useful for treating certain symptoms of endocrine disturbances, and in particular those associated with hot flashes. | 09-04-2014 |
20140309275 | Sphingosine Analogs, Compositions, and Methods Related Thereto - The disclosure relates to compounds, pharmaceutical compositions, and methods of treating or preventing disease. In certain embodiments, the disclosure relates to methods of treating an infection or cancer comprising administering a pharmaceutical composition disclosed herein to a subject in need thereof. In a typical embodiment, one administers a pharmaceutical composition comprising sphingosine or a sphingosine analog to a subject at risk for, exhibiting symptoms of or diagnosed with a malaria infection. | 10-16-2014 |